Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis

Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study

(2011) P. D. Miller et al.   OSTEOPOROSIS INTERNATIONAL

Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women

(2011) M. Osaki et al.   OSTEOPOROSIS INTERNATIONAL

Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension

(2011) G. Bianchi et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy and safety of monthly ibandronate in men with low bone density

(2010) Eric S. Orwoll et al.   BONE

Risk reduction of non-vertebral fractures with intravenous ibandronate: post-hoc analysis from DIVA

(2010) Philip Sambrook et al.   CURRENT MEDICAL RESEARCH AND OPINION

Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis

(2010) Harry K. Genant et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study

(2009) Robert R. Recker et al.   BONE

Ibandronate dose response is associated with increases in bone mineral density and reductions in clinical fractures: Results of a meta-analysis

(2008) Anthony I. Sebba et al.   BONE

Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension

(2008) Jacob A. Stakkestad et al.   CLINICAL RHEUMATOLOGY

Rapid Suppression of Bone Resorption Marker Levels With Ibandronate Therapy in a Bisphosphonate-Naïve Population

(2008) A.I. Sebba et al.   JOURNAL OF CLINICAL DENSITOMETRY

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data

(2008) A. Cranney et al.   OSTEOPOROSIS INTERNATIONAL